Primeira parte – Modo B-Learning (Out-Dez 2026)
Introdução ao curso e nomenclatura das Vasculites Sistémicas
Duração: 15–30 minutos
Módulo I – Vasculites de Grandes Vasos
Disponível a partir de 16 de outubro de 2026
Sessões teóricas
I.I. Epidemiology of LVV. Important distinctions between Giant Cell Arteritis and Takayasu Arteritis (20 min) Tomás Fonseca
I.II. Pathophysiology of LVV (30 min) Maria Cid
I.III. The clinical Spectrum of Giant Cell Arteritis and Polymyalgia Rheumatica (20 min) João Fernandes Serôdio
I.IV. Clinical features of Takayasu Arteritis (20 min) Tomás Fonseca
I.V. Imaging for the diagnosis and management of LVV (20 min) João Fernandes Serôdio
I.VI. “Subclinical” Giant Cell Arteritis (20 min) João Fernandes Serôdio
I.VII. Current treatment of Giant Cell Arteritis and Polymyalgia Rheumatica (30 min) João Fernandes Serôdio
I.VIII. Current treatment of Takayasu Arteritis (20 min) Tomás Fonseca
I.IX. Surgical and endovascular interventions in LVV (20 min) Andreia Pinelo
Interactive case solving
3 cases (20 min each).
Módulo II – Vasculites de Médios Vasos
Disponível a partir de 23 de outubro de 2026
Sessões Teóricas
II.I. Polyarteritis nodosa (30 min) António Marinho
II.II. Kawazaki disease (30 min) Andreia Martins
Interactive case solving
1 case (20 min).
Módulo III – Vasculites associadas aos ANCA
Disponível a partir de 30 de outubro de 2026
Sessões Teóricas
III.I. Epidemiology of AAV. Clinicopathologic phenotype and ANCA serotype (20 min) João Fernandes Serôdio
III.II. Pathophysiology of AAV (30 min) Peter Heeringa
III.III. Clinical features of AAV: focus on pulmonary-renal disease (20 min) Marta Casal Moura
III.IV. Clinical management of ENT and orbital involvement in AAV (20 min) José Hernández Rodríguez
III.V. Interstitial lung disease in AAV (20 min) Sergio Prieto González
III.VI. Less recognized features of AAV (20 min) João Fernandes Serôdio
III.VII. Current treatment of AAV (30 min) Marta Casal Moura
III.VIII. Eosinophilic Granulomatosis with Polyangiitis: from pathophysiology to clinical features (30 min) Tomás Fonseca
III.IX. Eosinophilic Granulomatosis with Polyangiitis: current treatment (30 min) Giacomo Emmi
Interactive case solving
3 cases (20 min each).
Módulo IV – Vasculites de Pequenos Vasos mediadas por Imunocomplexos
Disponível a partir de 16 de novembro de 2026
Sessões Teóricas
IV.I. IgA associated vasculitis (30 min) Fernando Salvador
IV.II. Cryoglobulinemic Vasculitis (30 min) Graziela Carvalheiras
IV.III. Hypocomplementemic Urticarial Vasculitis (20 min) Carolina Saca
IV.IV. Anti-Glomerular Basement Membrane Vasculitis (20 min) Sofia Correia
Interactive case solving
3 cases (20 min each).
Módulo V – Causas secundárias, Doenças Relacionadas e Diagnósticos diferenciais de Vasculites
Disponível a partir de 27 de novembro de 2026
Sessões Teóricas
V.I. IgG4-Related Disease: unifying pathophysiology of different clinical entities (30 min) Emanuel della Torre
V.II. IgG4-Related Disease: Current treatment (20 min) Tomás Fonseca
V.III. Monogenic forms of Vasculitis (30 min) António Lamas
V.IV. Secondary vasculitis: Lupus and rheumatoid vasculitis (30 min) José Delgado Alves
V.V. Vasculitis mimickers (20 min) Fernando Salvador
V.VI. Immune-checkpoint induced vasculitis (20 min) Tomás Fonseca
V.VII. Primary angiitis of the central nervous system and related disorders (20 min) Diogo Costa
Interactive case solving
2 cases (20 min each).
Módulo VI – Abordagem clínica para além da inflamação vascular
Disponível a partir de 11 de dezembro de 2026
Sessões Teóricas
VI.I. Infectious risk, prophylaxis and acquired hypogammaglobulinemia (20 min) João Fernandes Serôdio
VI.II. Osteoporosis and other corticosteroid related side-effects (20 min) Tomás Fonseca
VI.III. Cardiovascular risk and cancer in Systemic Vasculitis (20 min) Marta Matos
VI.IV. Chronic kidney disease and end-stage kidney disease in the context of vasculitis (20 min) Andreia Curto.
VI.V.. Pregnancy and vasculitis (20 min) Carolina Saca
VI.VI. Emergencies and intensive care in systemic vasculitis (20 min) Filipe Paula
Módulo VII – Perspetivas futuras nas vasculites
Disponível a partir de 18 de dezembro de 2026
VII.I Vasculitis and the Lab: when to perform ANCA screening, how to interpret results and other biomarkers of interest (20 min) Jan Demosieux
VII.II Vasculitis and the pathologist: clues to the interpretation of the histopathology findings in AAV and GCA (20 min) Nuno Lamas
VII.III. Immunogenetics of systemic vasculitis (20 min) Barbara Leal
VII.IV. Post-translational mechanisms in autoimmunity (20 min) Salomé S. Pinho
Segunda Parte – Presencial (30 de janeiro de 2027)
Module A – Clinical case presentation (CBL) Tomás Fonseca and João Fernandes Serôdio.
09h00-11h00
4 select cases will be presented by the participants in the course and discussed by the Faculty. Cases will be submitted as abstracts (300 words max.) by all participants 15 days before the In-person course (deadline 31st of December 2026)
Coffee break
11h30-13h30
Module B - Clinical case discussion (TBL) João Fernandes Serôdio and Tomás Fonseca
Cases to be solved by the students divided in groups.
Groups will have access to clinical symptoms. Complementary investigations will have to be chosen wisely to find the final diagnosis. Based on final diagnosis: adequate treatment and follow-up proposal must be done.
Lunch
Module B – Clinical trials in vasculitis (TBL) João Fernandes Serôdio and Tomás Fonseca
14h30-16h00
Three clinical trials will be presented by the faculty.
The studies should be reviewed by the student ahead of the session.
Discussion will be focused on data interpretation and trial methodology.
Students must understand the advances and limitations of each study.
Coffee break
Module D – Course assessment and closure. Tomás Fonseca, João Fernandes Serôdio
16h15-16h30
Course evaluation – feedback of the participants on the quality and organization of the course and speakers.
Closing of the course.
Avaliação Final do Curso
Exame online de escolha múltipla, realizado em inglês, abrangendo todos os conteúdos lecionados ao longo do curso.
Cada questão incluirá quatro opções de resposta, sendo apenas uma correta.
O exame estará disponível entre 1 e 14 de Fevereiro de 2027.
As sessões ficam disponíveis na plataforma até dia 14 de fevereiro de 2027. Após essa data os conteúdos são bloqueados.
